These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19846821)

  • 41. Expression of the p16(INK4a) gene product in premalignant and malignant epithelial lesions of the gallbladder.
    Lynch BC; Lathrop SL; Ye D; Ma TY; Cerilli LA
    Ann Diagn Pathol; 2008 Jun; 12(3):161-4. PubMed ID: 18486890
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Use of p16 in enhancing the histologic classification of uterine smooth muscle tumors.
    Atkins KA; Arronte N; Darus CJ; Rice LW
    Am J Surg Pathol; 2008 Jan; 32(1):98-102. PubMed ID: 18162776
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of carbohydrate antigens (SSEA-1, sialyl-Lewis X, DU-PAN-2 and CA19-9) and E-selectin in urothelial carcinoma of the renal pelvis, ureter, and urinary bladder.
    Kajiwara H; Yasuda M; Kumaki N; Shibayama T; Osamura Y
    Tokai J Exp Clin Med; 2005 Sep; 30(3):177-82. PubMed ID: 16285609
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CD138-positive plasmacytoid urothelial carcinoma of the bladder.
    Patriarca C; Di Pasquale M; Giunta P; Bergamaschi F
    Int J Surg Pathol; 2008 Apr; 16(2):215-7. PubMed ID: 18417684
    [No Abstract]   [Full Text] [Related]  

  • 45. [The mRNA expression of P16(ink4a) and HST2 in benign prostatic hyperplasia tissues: a pilot study].
    Xiong Y; Pan TJ; Ye ZQ
    Zhonghua Nan Ke Xue; 2008 Mar; 14(3):224-6. PubMed ID: 18488334
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Integrated genomic and transcriptional analysis of the in vitro evolution of telomerase-immortalized urothelial cells (TERT-NHUC).
    Chapman EJ; Williams SV; Platt FM; Hurst CD; Chambers P; Roberts P; Knowles MA
    Genes Chromosomes Cancer; 2009 Aug; 48(8):694-710. PubMed ID: 19405089
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunohistochemical detection of prostate-specific antigen expression in primary urothelial carcinoma of the urinary bladder.
    Chen JC; Ho CL; Tsai HW; Tzai TS; Liu HS; Chow NH; Yang WH; Cheng HL
    Anticancer Res; 2008; 28(6B):4149-54. PubMed ID: 19192675
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Utility of cytokeratin 5/6, cytokeratin 20, and p16 in the diagnosis of reactive urothelial atypia and noninvasive component of urothelial neoplasia.
    Edgecombe A; Nguyen BN; Djordjevic B; Belanger EC; Mai KT
    Appl Immunohistochem Mol Morphol; 2012 May; 20(3):264-71. PubMed ID: 22498670
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Do different disorders in cell cycle regulation account for different biological behavior of urothelial and sinonasal inverted papillomas?
    Gunia S; Fritzsche F; May M; Liebe D; Koch S
    Pathobiology; 2008; 75(1):34-41. PubMed ID: 18334838
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [FISH analysis in the differential diagnosis of flat urothelial lesions using tissue microarrays].
    Schwarz S; Rechenmacher M; Lottner C; Brockhoff G; Hartmann A; Langer S; Knüchel R
    Verh Dtsch Ges Pathol; 2004; 88():184-93. PubMed ID: 16892551
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ROS generation via NOX4 and its utility in the cytological diagnosis of urothelial carcinoma of the urinary bladder.
    Shimada K; Fujii T; Anai S; Fujimoto K; Konishi N
    BMC Urol; 2011 Oct; 11():22. PubMed ID: 22032647
    [TBL] [Abstract][Full Text] [Related]  

  • 52. How to combine the molecular profile with the clinicopathological profile of urothelial neoplastic lesions.
    van der Kwast TH
    Scand J Urol Nephrol Suppl; 2008 Sep; (218):175-84. PubMed ID: 18815932
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adding the p16(INK4a) marker to the traditional 3-marker (ER/Vim/CEA) panel engenders no supplemental benefit in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray study.
    Han CP; Lee MY; Kok LF; Ruan A; Wu TS; Cheng YW; Tyan YS; Lin CY
    Int J Gynecol Pathol; 2009 Sep; 28(5):489-96. PubMed ID: 19696622
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Histogenesis of clear cell adenocarcinoma in the urinary tract: evidence of urothelial origin.
    Sung MT; Zhang S; MacLennan GT; Lopez-Beltran A; Montironi R; Wang M; Tan PH; Cheng L
    Clin Cancer Res; 2008 Apr; 14(7):1947-55. PubMed ID: 18381932
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Editorial comment on: immunoreactivity of p63 in monolayered and in vitro stratified human urothelial cell cultures compared with native urothelial tissue.
    Papatsoris A; Deliveliotis C
    Eur Urol; 2008 May; 53(5):1073. PubMed ID: 17980953
    [No Abstract]   [Full Text] [Related]  

  • 56. Cytomorphology of urothelial carcinomatous peritoneal effusion.
    Xiao GQ
    Cytopathology; 2008 Apr; 19(2):131-3. PubMed ID: 18241206
    [No Abstract]   [Full Text] [Related]  

  • 57. High-grade urothelial carcinoma of the urinary bladder showing acquisition of microcystic histology in the penile metastasis: histogenetic considerations.
    Barresi V; Ieni A; Magno C; Barresi G
    Pathol Res Pract; 2009; 205(8):568-71. PubMed ID: 19179016
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of the urothelial differentiation markers GATA3 and placental S100 (S100P) in female genital tract transitional cell proliferations.
    Esheba GE; Longacre TA; Atkins KA; Higgins JP
    Am J Surg Pathol; 2009 Mar; 33(3):347-53. PubMed ID: 19092634
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnostic utility of antibody to smoothelin in the distinction of muscularis propria from muscularis mucosae of the urinary bladder: a potential ancillary tool in the pathologic staging of invasive urothelial carcinoma.
    Paner GP; Shen SS; Lapetino S; Venkataraman G; Barkan GA; Quek ML; Ro JY; Amin MB
    Am J Surg Pathol; 2009 Jan; 33(1):91-8. PubMed ID: 18936687
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Validation of World Health Organization/International Society of Urologic Pathology 2004 classification schema for bladder urothelial carcinomas using quantitative nuclear morphometry: identification of predictive features using bootstrap method.
    Kapur U; Antic T; Venkataraman G; Durazo-Arvizu R; Quek MM; Flanigan RC; Wojcik EM
    Urology; 2007 Nov; 70(5):1028-33. PubMed ID: 18068480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.